Literature DB >> 18804930

A catalog of SCN1A variants.

Christoph Lossin1.   

Abstract

Over the past 10 years mutations in voltage-gated sodium channels (Na(v)s) have become closely associated with inheritable forms of epilepsy. One isoform in particular, Na(v)1.1 (gene symbol SCN1A), appears to be a superculprit, registering with more than 330 mutations to date. The associated phenotypes range from benign febrile seizures to extremely serious conditions, such as Dravet's syndrome (SMEI). Despite the wealth of information, mutational analyses are cumbersome, owing to inconsistencies among the Na(v)1.1 sequences to which different research groups refer. Splicing variability is the core problem: Na(v)1.1 co-exists in three isoforms, two of them lack 11 or 28 amino acids compared to full-length Na(v).1.1. This review establishes a standardized nomenclature for Na(v)1.1 variants so as to provide a platform from which future mutation analyses can be started without need for up-front data normalization. An online resource--SCN1A infobase--is introduced.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18804930     DOI: 10.1016/j.braindev.2008.07.011

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  74 in total

1.  Severe Myoclonic Epilepsy in Infancy - Adult Phenotype with Bradykinesia, Hypomimia, and Perseverative Behavior: Report of Five Cases.

Authors:  P Martin; B Rautenstrauβ; A Abicht; J Fahrbach; S Koster
Journal:  Mol Syndromol       Date:  2011-03-26

2.  Crystal structure of the ternary complex of a NaV C-terminal domain, a fibroblast growth factor homologous factor, and calmodulin.

Authors:  Chaojian Wang; Ben C Chung; Haidun Yan; Seok-Yong Lee; Geoffrey S Pitt
Journal:  Structure       Date:  2012-06-14       Impact factor: 5.006

3.  Case-control association study of polymorphisms in the voltage-gated sodium channel genes SCN1A, SCN2A, SCN3A, SCN1B, and SCN2B and epilepsy.

Authors:  Larry Baum; Batoul Sadat Haerian; Ho-Keung Ng; Virginia C N Wong; Ping Wing Ng; Colin H T Lui; Ngai Chuen Sin; Chunbo Zhang; Brian Tomlinson; Gary Wing-Kin Wong; Hui Jan Tan; Azman Ali Raymond; Zahurin Mohamed; Patrick Kwan
Journal:  Hum Genet       Date:  2013-12-13       Impact factor: 4.132

4.  Alternative splicing of Na(V)1.7 exon 5 increases the impact of the painful PEPD mutant channel I1461T.

Authors:  Brian W Jarecki; Patrick L Sheets; Yucheng Xiao; James O Jackson; Theodore R Cummins
Journal:  Channels (Austin)       Date:  2009-07-23       Impact factor: 2.581

5.  Differential role of sodium channels SCN1A and SCN2A gene polymorphisms with epilepsy and multiple drug resistance in the north Indian population.

Authors:  Ram Lakhan; Ritu Kumari; Usha K Misra; Jayanti Kalita; Sunil Pradhan; Balraj Mittal
Journal:  Br J Clin Pharmacol       Date:  2009-08       Impact factor: 4.335

Review 6.  Sodium channel blockers for the treatment of neuropathic pain.

Authors:  Anindya Bhattacharya; Alan D Wickenden; Sandra R Chaplan
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

Review 7.  Voltage-sensor mutations in channelopathies of skeletal muscle.

Authors:  Stephen C Cannon
Journal:  J Physiol       Date:  2010-02-15       Impact factor: 5.182

8.  Comparison and optimization of in silico algorithms for predicting the pathogenicity of sodium channel variants in epilepsy.

Authors:  Katherine D Holland; Thomas M Bouley; Paul S Horn
Journal:  Epilepsia       Date:  2017-05-18       Impact factor: 5.864

9.  Strain- and age-dependent hippocampal neuron sodium currents correlate with epilepsy severity in Dravet syndrome mice.

Authors:  Akshitkumar M Mistry; Christopher H Thompson; Alison R Miller; Carlos G Vanoye; Alfred L George; Jennifer A Kearney
Journal:  Neurobiol Dis       Date:  2014-01-14       Impact factor: 5.996

10.  Human slack potassium channel mutations increase positive cooperativity between individual channels.

Authors:  Grace E Kim; Jack Kronengold; Giulia Barcia; Imran H Quraishi; Hilary C Martin; Edward Blair; Jenny C Taylor; Olivier Dulac; Laurence Colleaux; Rima Nabbout; Leonard K Kaczmarek
Journal:  Cell Rep       Date:  2014-12-04       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.